• Aparna S
• Abdul Rasheed A
• Balaji R
• Weslie Raj P
• Dr. V Dhanapal

In the field of eye therapy, ocular Inserts are a cutting-edge innovation. It has always been difficult for pharmaceutical researchers to design and produce an ocular insert. The brand-new medication delivery method, ocuserts is created in a way that prevents repeated drug administration by releasing the medicine at predetermined and predictable rates. 90% of the currently available optical formulations are available in conventional dosage forms. With traditional dosing formulations, a significant challenge has been the quick pre-corneal loss of medication. Significant recommendations have been made in favor of more modern drug delivery methods for ophthalmic administration to increase ocular medication bioavailability. The capacity to sustain a therapeutic level of the drug at the site of action for an extended duration of time is one of the primary obstacles in ocular therapy. Ocular Inserts are described as sterile, thin, solid, or semi-solid constancy devices that are sized and shaped specifically for ophthalmic delivery and are put into a cul-de-sac or conjunctiva sac. The advantages of ocular Inserts over traditional dose forms are highlighted in the review study.

Ocuserts, Ophthalmic delivery, Bioerodible, Polymers, Lens

"Novel Controlled Drug Delivery System: A Review of Ocular Insert", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 11, page no.c711-c721, November-2023, Available :http://www.jetir.org/papers/JETIR2311297.pdf

"Novel Controlled Drug Delivery System: A Review of Ocular Insert", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 11, page no. ppc711-c721, November-2023, Available at : http://www.jetir.org/papers/JETIR2311297.pdf